Acorda Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$266.9M

2,672 transactions

Summary

Acorda Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $17.1MSales: $210.0M39 insiders

Date	Insider	Type	Value
2023-03-17	COHEN RON(President and CEO)	Buy	$7K
2023-03-16	COHEN RON(President and CEO)	Buy	$6K
2022-03-17	COHEN RON(President and CEO)	Sell	$4K
2022-09-03	Clem Kerry M(Chief Commercial Officer)	F	$604.4
2022-09-03	Sabella Lauren M(Chief Operating Officer)	F	$604.4
2023-06-22	Jensen Peder	A	$0
2023-06-22	Kelley John P	A	$0
2023-06-22	PANEM SANDRA PHD	A	$0
2023-06-22	Varian John	A	$0
2023-06-22	BURNS THOMAS M.	A	$0
2023-03-31	Belloff Neil S.(General Counsel and Corp Secy)	A	$0
2023-03-31	Clem Kerry M(Chief Commercial Officer)	A	$0
2023-03-31	COHEN RON(President and CEO)	A	$0
2023-01-01	Varian John	A	$0
2022-06-10	Jensen Peder	A	$0
2022-06-10	Kelley John P	A	$0
2022-06-10	PANEM SANDRA PHD	A	$0
2022-06-10	Randall Lorin	A	$0
2022-01-01	Varian John	A	$0
2021-11-12	COHEN RON(President and CEO)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Acorda Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope